Management of Recurrent Venous Thromboembolism

  • Kenneth M. Moser


Despite gains in our abilities to identify patients at high risk of venous thromboembolism and provide them with rather safe and effective forms of primary prophylaxis (1–5), venous thromboembolism (V T-E) continues to occur at a substantial rate. Part of the problem is a failure to recognize the high risk patient; part, limited application of the available prophylactic options. Clearly, educative and logistic initiatives are still needed in many health care facilities, the key ingredient being a physician catalyst who can carry forward a primary prophylaxis program.


Deep Vein Thrombosis Deep Venous Thrombosis Venous Thromboembolism Clinical Risk Factor Inferior Vena Caval Filter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Crandon, A.J., Peel, K.R., Anderson, J.A., Thompson, V., McNicol, G.P. Post-operative deep vein thrombosis: identifying high risk patients. Brit. Med. J., 281:343–44, 1980.PubMedCrossRefGoogle Scholar
  2. 2.
    Sue-Ling, H.M., McMahon, M.J., Johnston, D., Philips, P.R., Davies, J.A. Pre-operative identification of patients at high risk of deep venous thrombosis after major abdominal surgery. The Lancet, 1:1173–1176, 1986.CrossRefGoogle Scholar
  3. 3.
    Consensus Conference: Prevention of Venous Thrombosis and Pulmonary Embolism. JAMA, 256:744–749, 1986.CrossRefGoogle Scholar
  4. 4.
    Havig, O. Deep vein thrombosis and pulmonary embolism. Chir. Scand., 478, 1–93, 1978.Google Scholar
  5. 5.
    The Epidemiology of Venous Thrombosis. The Milbank Memorial Fund Quarterly, 50:1–283, 1972.Google Scholar
  6. 6.
    Moser, K.M. and Fedullo, P.F., Venous thromboembolism: three simple decisions, 83:117–121, 256–260, 1983.Google Scholar
  7. 7.
    Moser, K.M., Spragg, R.G., Utley, J., Daily, P.O. Chronic thrombotic obstruction of major pulmonary arteries. Ann. Int. Med., 99:299–305, 1983.PubMedCrossRefGoogle Scholar
  8. 8.
    Moser, K.M., Daily, P.O. and Peterson, K.L. Management of chronic unresolved large vessel thromboembolism in, the Pulmonary Circulation in Health and Disease (Ed: J.A. Will) Academic Press. (In press)Google Scholar
  9. 9.
    Moser, K.M., LeMoine, J.R. Is embolic risk conditioned by location of deep venous thrombosis? Ann. Int. Med, 94:439–434, 1981.PubMedCrossRefGoogle Scholar
  10. 10.
    Hull, R.D., Hirsh, J., Carter, C.J, et al. Diagnostic efficacy of impedance plethysmography for clinically suspected deep vein thrombosis. Ann. Int. Med., 102:21–28, 1985.PubMedCrossRefGoogle Scholar
  11. 11.
    Huisman, M.V., Buller, H.R., Ten Cate, J.W, Vreeken, J. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. New Engl. J. Med., 314:823–828, 1986.PubMedCrossRefGoogle Scholar
  12. 12.
    Hull, R.D., Hirsh, J., Carter, C.J. et al. Pulmonary angiography, ventilation lung scanning and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann. Int. Med., 98:891–899, 1983.PubMedCrossRefGoogle Scholar
  13. 13.
    Moser, K.M. Asymptomatic pulmonary embolism. JAMA, 247:1049, 1982.CrossRefGoogle Scholar
  14. 14.
    Brach, B.B., Moser, K.M., Cedar, L., et al. Venous thrombosis in acute spinal cord paralysis. J. Trauma, 17:289–292, 1977.PubMedCrossRefGoogle Scholar
  15. 15.
    Marder, V.J., Souler, R.L., Aticharthkarn, V., et al. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J. Lab. Clin. Med., 89:1018–24, 1977.PubMedGoogle Scholar
  16. 16.
    Robertson, B.R., Nilsson, I.M., and Nylander, G. Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg. Act. Chir. Scand., 136:173–178, 1970.Google Scholar
  17. 17.
    Goldhaber, S.Z., Buring, J.E., Lipnick, R.L., Hennekens, C.H. Pooled analysis of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am. J. Med., 76:393–397, 1984.PubMedCrossRefGoogle Scholar
  18. 18.
    Hull, R., Carter, C, Jay, R.M., et al. The diagnosis of acute, recurrent deep vein thrombosis: A diagnostic challenge. Circ., 67:901–906, 1983.CrossRefGoogle Scholar
  19. 19.
    Nelson, P.H., Moser, K.M., Stover, C., Moser, K.S. Risk of complications during intravenous heparin therapy. West J. Med., 136:189–197, 1982.PubMedGoogle Scholar
  20. 20.
    Pettiti, D.R., Strom, B.L., Melmon, K.L. Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage. Am. J. Med., 81:255–259, 1986.CrossRefGoogle Scholar
  21. 21.
    Greenfield, L.J. A new intracaval filter permitting continued flow and resolution of emboli. Surg., 73:599–605, 1973.Google Scholar
  22. 22.
    Greenfield, L.J. Greenfield vena caval filter experience. Arch. Surg., 116:1451–55, 1981.PubMedCrossRefGoogle Scholar
  23. 23.
    Hull, R., Delmore, T., Carter, C, et al. Adjusted subcutaneous heparin vs warfarin sodium in the long-term treatment of venous thrombosis. New Engl. J. Med., 306:189–194, 1982.PubMedCrossRefGoogle Scholar
  24. 24.
    Hull, R., Hirsh, J., Jay, R., et al. Different intersities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. New Engl. J. Med., 307:1676–1681, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Kenneth M. Moser
    • 1
  1. 1.School of MedicineUniversity of California, San DiegoSan DiegoUSA

Personalised recommendations